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Background: Administration of KA on rodents has resulted in seizures, behavioral changes, oxidative stress, and
neuronal degeneration on selective population of neurons in the brain. The present study was undertaken to
investigate the extent of neuroprotective effect conferred by Malaysian Tualang Honey (TH), an antioxidant agent,
in the cerebral cortex of rats against KA-induced oxidative stress and neurodegeneration in an animal model of KA-
induced excitotoxicity.
Methods: Male Sprague–Dawley rats were randomly divided into five groups: Control, KA-treated group, TH + KA-
treated group, aspirin (ASP; anti-inflammatory agent) + KA-treated group and topiramate (TPM; antiepileptic agent) +
KA-treated group. The animals were pretreated orally with drinking water, TH (1.0g/kg BW), ASP (7.5mg/kg BW) or TPM
(40mg/kg BW), respectively, five times at 12 h intervals. KA (15mg/kg BW) was injected subcutaneously 30 min after last
treatment to all groups except the control group (normal saline). Behavioral change was observed using an open field
test (OFT) to assess the locomotor activity of the animals. Animals were sacrificed after 2 h, 24 h and 48 h of KA
administration.
Results: KA significantly inflicted more neuronal degeneration in the piriform cortex and heightened the predilection
to seizures as compared with the control animals. Pretreatment with TH reduced the KA-induced neuronal
degeneration in the piriform cortex but failed to prevent the occurrence of KA-induced seizures. In the OFT, KA-
induced animals showed an increased in locomotor activity and hyperactivity and these were attenuated by TH
pretreatment. Furthermore, TH pretreatment significantly attenuated an increase of thiobarbituric acid reactive
substances level and a decrease of total antioxidant status level enhanced by KA in the cerebral cortex.
Conclusion: These results suggest that pretreatment with TH has a therapeutic potential against KA-induced
oxidative stress and neurodegeneration through its antioxidant effect.
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Excitotoxicity has been considered to be a major patho-
logical process of neuronal death in acute and chronic
neurodegenerative diseases such as Alzheimer’s disease,
Parkinson’s disease, Huntington’s disease, temporal lobe
epilepsy (TLE), amyotrophic lateral sclerosis and hyp-
oxia/ischemia [1]. Kainic acid (KA), a neurotoxicant ex-
tracted from red alga, Digenea simplex, is widely used to
induce seizures and to explore the mechanism of excito-
toxicity and neurodegeneration. Studies on KA-induced
animal experimental model have shown series of clinical
manifestations and pathological changes upon KA ad-
ministration on rodents such as seizures [2], behavioral
changes of rodents [3, 4], oxidative stress [5, 6] and
neuropathological lesions akin to those found in patients
with TLE [7].
In recent decades, there is an emerging trend to search
for natural resources to combat against neurodegenera-
tive diseases. Many studies have tested or reported the
protective effect of various types of natural products
against KA-induced excitotoxicity models [3, 8–11].
Many of natural products possess antioxidant activity
that enables them to protect against KA –induced neur-
onal degeneration and KA-induced seizures. In Malaysia,
Tualang honey (TH) is widely used as a nutrient supple-
mentation and in traditional medicine. TH is a wild
multiflora honey produced by Asian rock bees (Apis
Dorsata). The honey bears its name after a tall Tualang
tree (Koompassia excelsa) where Asian rock bees build
their hives. Tualang tree can be found mostly in the
tropical rain forest in the northern peninsular Malaysia,
southern Thailand and Borneo. TH has been reported to
contain many bioactive compounds which include benzoic
acid, gallic acid, syringic acid, p-coumaric acid, trans-
cinnamic acid, caffeic acid, ferulic acid, chlorogenic acid,
catechin, quercetin, kaempferol, naringenin, pinobanksin-
3-O-propionate and pinobanksin-3-O-butyratengenin
[12, 13]. TH has also been shown to have beneficial effect
at a dose of 1.0 g/kg body weight in diabetic [14] and
ovariectomized [15] rats. Studies have demonstrated that
TH could improve spatial learning and memory perform-
ance during chronic cerebral hypoperfusion-induced neu-
rodegeneration [16] and induce protective effect against
chronic cerebral hypoperfusion-induced neurodegenera-
tion [17]. In addition, studies have reported that TH
consumption could deter hippocampal morphological im-
pairment in adult male rats [18] and improve hippocampal
morphological impairment in ovariectomized rats [19]. In
light of these data, we hypothesized that the protective ef-
fect of TH could be partly mediated through ameliorating
the oxidative stress, afforded by it’s rich phenolic and fla-
vanoid antioxidants.
Despite the growing body of evidence on TH antioxi-
dant and anti-inflammatory actions, its neuroprotectiveactivity in the animal model of KA-induced excitotoxi-
city has remained unexplored. Therefore, this study was
carried out to investigate the potential neuroprotective
effect and its possible mechanism of TH against the KA-
induced oxidative stress and neurodegeneration on rat
cerebral cortex in an animal model of KA-induced exci-
totoxicity. Moreover, the significance of a blockade of
the cyclooxygenase (COX) pathway and the modulatory
effect on Kainate receptors (KARs) were also determined
by comparing the pretreatment between TH and aspirin
(ASP) (non-selective inhibitor of COX) and between TH
and topiramate (TPM) (its modulatory effect on KARs)
to extend our understanding of the pharmacological
intervention of TH. Previous studies have suggested that
ASP and TPM appeared to alleviate the neurotoxicity in-
duced by KA [20, 21].
Methods
The experimental protocol was reviewed and approved
by the Animal Ethic Committee of USM [USM/Animal
Ethics Approval/2011/(68) (305)]. All procedures were
conducted according to guidelines approved by the
Animal Ethic Committee of USM. All efforts were made
to minimize the number of animals used necessary to
produce reliable scientific data and to lessen animal suf-
fering. All the section of this report was written up in
accordance with the Animal Research: Reporting in Vivo
Experiment (ARRIVE) Guidelines for reporting animal
research [22]. A completed ARRIVE guidelines checklist
is included in Additional file 1.
Experimental animals
Male, Sprague–Dawley rats, aged 8 weeks were obtained
from Animal Research and Service Center (ARASC),
Universiti Sains Malaysia (USM) Health Campus. Ani-
mals were housed individually in polypropylene cages
with soft bedding in the ARASC housing facility. They
were maintained in a well-ventilated animal room at
temperature of 21 ± 2 °C under a standard animal room
condition of a 12-h light/dark cycle. Animals had free
access to drinking water and food pellets ad libitum. An-
imals were acclimatized for at least a week and they
were observed closely for any abnormality to ensure that
they were in good health before starting the experiment.
No abnormalities were observed.
Materials
All chemicals and reagents used in this study were of
analytical grade. KA and ASP were purchased from
Sigma-Aldrich Co., St. Louis, MO. Tualang honey
(AgroMas®) was supplied by Federal Agricultural
Marketing Authority (FAMA), Kedah, Malaysia. TPM
was purchased from Tokyo Chemical Industry Co., Ltd.,
Japan. Fluoro Jade C (FJC) powder was purchased from
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chased from Merck, Germany.
Experimental design
Male, Sprague–Dawley rats, (aged 9 – 11 weeks)
weighing (mean ± SD) 290 ± 30 g were used in this
study. Two set of animals were carried out; one set
was for study 1; behavioral and biochemical studies
(N = 90) and another set was for study 2; histology
study (N = 90). For each set, animals were randomly
divided into five major groups (n = 18/group) and
each major group was further randomly divided into
three subgroups depending on the time of sacrifice
(after 2 h, 24 h and 48 h of KA administration), with
a total of 15 subgroups (n = 6/subgroup). All treat-
ments were conducted at the day session (between 8 am
and 10 am) and at the night session (between 8 pm and
10 pm) for each treatment day.
i. Group 1: The saline-treated group (control group) -
Animals were treated orally with drinking water five
times every 12 h.
ii. Group 2: The KA only-treated group - Animals were
treated orally with drinking water five times every
12 h.
iii. Group 3: The TH + KA-treated group -Animals
were treated orally with TH (1.0 g/kg body weight)
five times every 12 h. The TH dose of 1.0 g/kg
body weight was chosen as it was previously
shown to have beneficial effect in diabetic [14]
and ovariectomized [15] rats.
iv. Group 4: The TPM + KA-treated group - Animals
were treated orally with TPM (40 mg/kg body weight)
five times every 12 h. The dosage was chosen based
on other studies using topiramate [23–25].
v. Group 5: The ASP + KA-treated group - Animals
were treated orally with ASP (7.5 mg/kg body
weight) five times every 12 h. The dosage was
chosen based on Kim et al. study [20].
Kainic acid administration
Thirty minutes after the last administration of drinking
water or honey or drugs respectively, KA (15 mg/kg
body weight; 10 mg/ml in normal saline) was admin-
istered subcutaneously (s.c.) to all groups except for
the control group, which received subcutaneous injec-
tion of normal saline. The dose of KA (15 mg/kg
body weight; s.c.) has been previously reported to be
sufficient to inflict a significant injury in the different
regions of the brain (i.e. amygdala, hippocampus and
cortex) and all tested parameters (i.e. citrulline level,
total adenine nucleotides and total creatine com-
pounds), to reach their peaks after 2 h following KA
administration [26].Seizure characteristics
Following KA administration, animals were monitored
for 4 h and the time to the onset of first generalized
tonic-clonic seizures (characterized by stage 4 described
by Zhang et al. [2]) was recorded. Since this study used
single high dose KA treatments which were associated
with a high mortality rate, special efforts were made to
improve the survival rate of KA-treated animals. To re-
duce mortality [27], diazepam (10 mg/kg body weight;
Atlantic Laboratories Corp. Ltd., Thailand) was adminis-
tered intraperitoneally, approximately 90 min after the
first generalized seizure to animals of 24 h and 48 h sub-
group, except for the control groups, which received an
equivalent amount of normal saline. Subcutaneous nor-
mal saline injection was administered periodically during
the first 24 h recovery period.
The open-field test procedure
For the study 1 only, behavioral change was observed
using an open field test (OFT) to assess the locomotor
activity of animals. With the exception of 2 h subgroups,
locomotor activity of animals was documented in the
24 h and 48 h subgroups from each major group.
The animals were tested one at a time and handled
by their tails at all times. The animals were individu-
ally placed at the central square of the OFT apparatus
(90 cm x 90 cm x 27 cm, consisting of 25 equally
sized squares measuring 18 cm x 18 cm each). Ani-
mals were allowed to explore freely the area for 15 min
while the locomotor activity was recorded using the
video-tracking system. After each trial, the animals were
returned to their cage and the apparatus was cleaned be-
tween each rat using 30% ethyl alcohol and allowed to dry
between trials. All tests were conducted between 8 am
and 2 pm. The OFT was performed using an in-house
built-in OFT apparatus from the Department of
Neurosciences, School of Medical Sciences Universiti
Sains Malaysia, Kelantan, Malaysia and SMART soft-
ware (Panlab, Harvard) from BRAINetwork, Universiti
Sains Malaysia, Kelantan, Malaysia. Locomotor activity
of animals was assessed based on the number of line
crossing (the frequency of crossing one of the black
grid lines with all four paws) in the OFT apparatus in
15 min duration. The behavioral of animals were ob-
served and analyzed by an observer blinded with re-
spect to the experimental groups.
Preparation of tissue samples
For the study 1, depending on the time of sacrifice (after
2 h, 24 h and 48 h of KA administration), following the
completion of the behavioral experiment, all major
group of rats were decapitated using guillotine (Harvard
Apparatus, USA) after 2 h, 24 h and 48 h of KA admin-
istration with the respective control groups. The cerebral
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oughly washed with an ice-cold (0° - 4 °C) normal saline
to remove any excess blood. The cerebral cortex was
minced to small pieces and homogenized to make 7.5%
(w/v) homogenates in ice-cold 0.1 M sodium phosphate
buffer, Ph 7.4, using ice-chilled glass-homogenizing ves-
sel in a tissue homogenizer fitted with Teflon pestle
(Glas-Col, USA) at 900 rpm for 90 s. Then, the homoge-
nates were centrifuged in a refrigerated centrifuge at
4000 rpm for 15 min at 4 °C to remove nuclei and deb-
ris. The resulting supernatant fraction of homogenates
was used for the measurement of lipid peroxidation and
total antioxidant status.
For the study 2, depending on the time of sacrifice
(2 h, 24 h and 48 h of KA administration), all major
groups of rats were deeply anesthetized with a mix-
ture of ketamine/xylazine (90 mg/kg body weight
ketamine and 5 mg/kg body weight xylazine), via
intramuscular injection. The toe pinch-response method
was used to determine the depth of anesthesia and
animals must be unresponsive before commencing
perfusion process. The anaesthetized rat was transcar-
dially perfused with ice-cold phosphate buffer saline,
pH 7.4 and followed by ice-cold 4% paraformaldehyde
in 0.2 M sodium phosphate buffer, pH 7.4 after 2 h,
24 h and 48 h of KA administration with the respect-
ive control groups. Brains were rapidly removed from
skulls. The cerebrum was dissected and separated
from the rest of the brain and then immersed in the
same fixative solution at 4 °C for overnight. After
post-fixation, the cerebrum was processed, embedded
in paraffin and sectioned into serial 5-μm-thick cor-
onal sections, taken from 4.60 mm and 3.60 mm with
respect to a relative distance from Bregma [28]. Prior
to histochemical staining, the sections were mounted
onto poly-L-lysine coated slides and were air dried
for overnight. The slides were stained with cresyl-
violet stain and Fluoro Jade C (FJC) to examine de-
generating neurons.
Determination of thiobarbituric acid reactive substances
and total antioxidant status level
The measurement of lipid peroxidation was determined
by estimating Thiobarbituric Acid Reactive Substances
(TBARS), according to the method previously de-
scribed by Ohkawa et al. [29] with some modifica-
tions. TBARS level (lipid peroxidation) was expressed
as nanomoles of Malondialdehyde equivalent per g
wet tissue (nanomoles/g wet tissue). Meanwhile, total
antioxidant status (TAS) of the homogenate sample
was determined as previously described by Koracevic
et al. [30]. TAS level was expressed as nanomoles of
uric acid equivalent per g wet tissue (nanomoles/g
wet tissue).Evaluation of viable cells using cresyl violet staining
Cresyl violet staining was performed to provide the esti-
mation of neuronal loss. Cresyl violet staining stock so-
lution was prepared by dissolving 0.1 g cresyl violet
acetate powder (Merck, Germany) in 75 ml of distilled
water. Then, 6 ml of cresyl violet stock solution was di-
luted with 50 ml of 0.1 M acetate buffer (pH 3.6) to
make cresyl violet working solution.
In brief, slides were treated sequentially with the fol-
lowing steps. First, the sections were deparaffinized with
xylene and a series of descending grade of ethanol
(100%, 95% and 80%) and then brought to water. Follow-
ing tissue hydration, the sections were stained with cre-
syl violet and then rinsed with distilled water. The
sections were air dried overnight, cleared in xylene and
then cover slipped with Dibutylphthalate Polystyrene
Xylene (DPX) mounting media (Sigma, USA).
The cresyl violet-stained sections were visualized and
imaged using Olympus BX41 microscope equipped with
a high resolution digital camera system and a desktop
computer preinstalled with image analysis software, ana-
lySIS FIVE. Viable cells were counted and defined as
cells with normal morphology, exhibiting round nuclei
stained with cresyl violet-stained.
Evaluation of degenerating neurons using Fluoro Jade C
staining
In order to further evaluate neuronal degeneration in
the cortex of rats, FJC histochemical staining was per-
formed using the method described by Schmued et al.
[31]. FJC is an anionic fluorescent dye, a specific marker
of degenerating neurons. FJC staining stock solution was
prepared by dissolving 10 mg of dry powder FJC (Histo-
Chem Inc., USA) in 100 ml distilled water. Then, 10 ml
of stock solution was added to 90 ml of 0.1% acetic
acid, producing 0.001% concentration of FJC working
solution.
In brief, slides were then treated sequentially with the
following steps: sections were deparaffinized with xylene
and a series of descending graded series of ethanol
(100%, 95% and 80%) and then immersed in distilled
water. After tissue hydration, slides were immersed in
0.1% potassium permanganate solution for 20 min with
slow shaking in the dark and then rinsed with distilled
water for 2 min. Slides were incubated in 0.001% FJC in
0.1% acetic acid for 10 min with slow shaking in the
dark. Then, slides were rinsed 3 times with distilled
water. The sections were air dried overnight, cleared in
xylene and then cover slipped with DPX mounting
media (Sigma, USA).
The FJC-labelled sections were visualized and im-
aged using an Olympus BX41 fluorescence micro-
scope using a filter system designed for visualizing
fluorescein (Excitation peak:4 nm, Emission peak: 525 nm)
Table 1 Effect of KA-induced excitotoxicity on the time to the
onset of the first generalized seizures between groups
Group Onset time of the first
generalized seizures (min)
Median (IqR) (n = 12)
Kruskal-Wallis test (N = 48)
χ2 stat (df) p value
KA 76.50 (38.50) 4.72 (3) 0.1937
TH + KA 65.00 (23.50)
TPM + KA 64.50 (23.50)
ASP + KA 62.50 (13.25)
The results were expressed as the median (IqR). The significant difference was
determined by non-parametric test, Kruskal-Wallis test. Mann-Whitney U test
was not performed because there was no significant difference (p > 0.05) in
the median values with Kruskal-Wallis test
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desktop computer preinstalled with image analysis soft-
ware, analySIS FIVE. Fluoro-jade-positive cell were
counted and defined as a bright green fluorescence, while
normal neurons appeared even darker than background
with lightly staining nucleoli or were unstained.
Neuronal quantification
Three representative sections of the cerebrum were se-
lected for each animal that were used to quantify neur-
onal degeneration. These sections were taken from
Bregma 4.60 mm to Bregma 3.60 mm [28] at a regular
space interval of 100 μm with 5 μm thick for each rat
from each group. Using analySIS FIVE image analysis
software, five non-overlapping areas were identified on
piriform cortex and photographed at 200x magnification.
The data of these images were saved into computer.
Three of these images were randomly selected for neur-
onal quantification. Neuronal cell counts were per-
formed using Image J image analysis software (National
Institute of Health, USA) and the data were then aver-
aged for each animal. The neuronal quantification was
performed by an observer blinded with respect to the
experimental groups.
Statistical analysis
All data were analyzed using SPSS software version 22
(SPSS Statistics IBM, Chicago, USA). Statistical signifi-
cance of differences was determined by Kruskal-Wallis
followed by Mann–Whitney U (MW) test. Data was
considered statistically significant when p value was less
than 0.05 (p < 0.05). Results are expressed as median
(Interquartile Range; IqR).
Results
Administration of KA induced seizures
Administration of KA (15 mg/kg body weight, s.c.) in-
duced epileptic seizures in all KA-treated rats and KA-
treated groups that received pretreatment of TH, ASP
and TPM. No seizure behavior was observed in the con-
trol group. The onset of seizure occurred most fre-
quently within 1 h to 4 h post-KA administration. All
KA-treated rats exhibited progressive motor seizures. It
started with staring spells in which rats seemed to be in
a motion arrest. This was followed by wet dog shakes
which progressively became frequent in nature. Then,
the animals displayed hyperactive behavior in which they
had repeated head nodding with the intervals of con-
tinuous walking and chewing. After that, rats started to
rear up on their hind limbs and then developed frequent
and prolonged rearing, accompanied by forelimb clonic
jerks, salivation and white foaming at the mouth (first
generalized seizure). Next, the rats were falling or had
loss of balance while rearing. These rearing and fallingepisodes continued until the rats were injected with di-
azepam (10 mg/kg body weight) approximately 90 min
following the onset of the first generalized seizure. The
rats in the control group displayed normal behavior such
as walking, sniffing, grooming and exploring.
Statistical analysis indicated that there was no signifi-
cant difference (p > 0.05) in the time to the onset of the
first generalized seizures between groups, [χ2 (3) = 4.72,
(N = 48), p = 0.1937] (Table 1). The median values of the
time to the onset of the first generalized seizures in the
KA-induced rats pre-treated with TH, ASP and TPM
were no significantly different (p > 0.05) from those of
the KA-induced rats. Therefore, pretreatment with TH,
ASP and TPM did not have any apparent anticonvulsant
effect in KA-induced seizures.
Effect of KA-induced excitotoxicity on the number of line
crossing in the OFT
Statistical analysis of number of line crossing in the
OFT indicated that there was a significant difference
(p < 0.05) in the number of line crossing between the
groups for all 24 h and 48 h subgroups of KA admin-
istration, as shown in Table 2 [24 h subgroups = χ2
(4) =19.79, (N = 30), p = 0.0005; 48 h subgroups = χ2
(4) = 11.71, (N = 30), p = 0.0196]. Post hoc test re-
vealed there was a significant difference (p < 0.05) in
the number of line crossing in the OFT between the
control and KA-treated groups in 24 h and 48 h sub-
groups, and between the control and KA-induced
groups pre-treated with TPM for 24 h subgroups of
KA administration. In the OFT, KA-treated group
was increased in the locomotor activity (based on
number of line crossing) and hyperactivity.
There was also a significant difference (p < 0.05) in the
number of line crossing in the OFT between KA-treated
groups and KA-induced groups pre-treated with TH of
24 h and 48 h of KA administration (Table 2). This indi-
cated that the increased locomotor activity induced by
KA was attenuated by TH pre-treatment. There was a
significant difference (p < 0.05) in the number of line
Table 2 Effect of KA-induced excitotoxicity on the number of line crossing in the OFT
Subgroups Number of line crossing
Median (IqR) (n = 6)
Kruskal-Wallis test (N = 30)
CONTROL KA TH + KA TPM + KA ASP + KA χ2 stat (df) p value
24H 190.00 (57.00) 259.50 (50.50)a 160.50 (45.50)b 101.00 (57.75)a,b 120.00 (170.25)b 19.79 (4) 0.0005
48H 143.00 (41.75) 197.50 (21.25)a 135.00 (20.75)b 169.00 (153.25) 123.50 (82.00)b 11.71 (4) 0.0196
The results were expressed as the median (IqR). The significant difference was determined by non-parametric test, Kruskal-Wallis test followed by Mann-Whitney U
post-hoc test with p < 0.05 indicates statistically significant difference. ap < 0.05 versus control group (MW); bp < 0.05 versus KA group (MW)
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KA-induced groups pre-treated with TPM for 24 h sub-
groups of KA administration, and between KA-treated
groups and KA-induced groups pre-treated with ASP of
24 h and 48 h of KA administration.
Effect of KA-induced excitotoxicity on TBARS level in the
cerebral cortex
Statistical analysis of the TBARS level in the cerebral
cortex indicated that there was a significant difference
(p < 0.05) in the TBARS level between the groups for all
2 h, 24 h and 48 h subgroups of KA administration,
as shown in Table 3 [2 h subgroups = χ2 (4) = 22.63,
(N = 30), p = 0.0002; 24 h subgroups = χ2 (4) = 24.18,
(N = 30), p = 0.0001; 48 h subgroups = χ2 (4) = 22.97,
(N = 30), p = 0.0001].
Post hoc test showed that there was a significant dif-
ference (p < 0.05) in the TBARS level between the con-
trol and all the treatment groups that received KA, for
all 2 h, 24 h and 48 h subgroups of KA administration,
except for between control groups and KA-induced
groups pre-treated with TH and TPM after 2 h of KA
administration. The analysis indicated that the TBARS
level in KA- treated, TH + KA treated, TPM+KA
treated and ASP + KA treated groups were significantly
higher as compared with relative control groups after
2 h, 24 h and 48 h following KA administration, re-
spectively (Table 3).
There was also a significant difference (p < 0.05) in the
TBARS level between KA-treated groups and KA-
induced groups pre-treated with TH after 2 h, 24 h and
48 h of KA administration (Table 3). This showed thatTable 3 Effect of KA-induced excitotoxicity on TBARS level in the ce
Subgroups TBARS (nanomoles/g wet tissue)
Median (IqR) (n = 6)
CONTROL KA TH + KA
2H 11.95 (2.90) 21.93 (1.78)a 15.40 (3.72)b
24H 13.54 (3.38) 101.55 (11.48)a 75.70 (8.25)a,b
48H 12.55 (2.21) 81.39 (10.87)a 54.21 (9.32)a,b
The results were expressed as the median (IqR). The significant difference was dete
post-hoc test with p < 0.05 indicates statistically significant difference. ap < 0.05 versus
group (MW)TH pre-treatment significantly attenuated an increase of
TBARS level induced by KA. There was also a signifi-
cant difference (p < 0.05) in the TBARS level between
KA-treated groups and KA-induced groups pre-treated
with TPM and ASP after 2 h, 24 h and 48 h of KA ad-
ministration (Table 3). In addition, there was a signifi-
cant difference in the TBARS level between KA-induced
groups pre-treated with TH and KA-induced groups
pre-treated with ASP after 24 h of KA administration.
Effect of KA-induced excitotoxicity on TAS level in the
cerebral cortex
Statistical analysis of the TAS level in the cerebral
cortex indicated that there was a significant difference
(p < 0.05) in the TAS level between the groups for all
2 h, 24 h and 48 h subgroups of KA administration,
as shown in Table 4 [2 h subgroups = χ2 (4) = 25.13,
(N = 30), p = 0.0000; 24 h subgroups = χ2 (4) = 23.69,
(N = 30), p = 0.0001; 48 h subgroups = χ2 (4) = 25.36,
(N = 30), p = 0.0000].
Post hoc test indicated that there was a significant
difference (p < 0.05) in the TAS level between the
control and all the treatment groups that received
KA, for all 2 h, 24 h and 48 h subgroups of KA ad-
ministration. The results of analysis also showed that
the TAS level in KA- treated, TH + KA treated, TPM+KA
treated and ASP + KA treated groups were significantly
lowered as compared with relative control groups
after 2 h, 24 h and 48 h following KA administration,
respectively (Table 4).
There was also a significant difference (p < 0.05) in the
TAS level between KA-treated groups and KA-inducedrebral cortex
Kruskal-Wallis test (N = 30)
TPM + KA ASP + KA χ2 stat (df) p value
15.35 (4.08)b 18.35 (1.31)a,b 22.63 (4) 0.0002
80.19 (9.17)a,b 82.38 (6.69)a,b,c 24.18 (4) 0.0001
57.64 (5.14)a,b 56.46 (8.44)a,b 22.97 (4) 0.0001
rmined by non-parametric test, Kruskal-Wallis test followed by Mann-Whitney U
control group (MW); bp < 0.05 versus KA group (MW); cp < 0.05 versus KA + TH
Table 4 Effect of KA-induced excitotoxicity on TAS level in the cerebral cortex
Subgroups TAS (nanomoles/g wet tissue)
Median (IqR) (n = 6)
Kruskal-Wallis test (N = 30)
CONTROL KA TH + KA TPM + KA ASP + KA χ2 stat (df) p value
2H 789.62 (31.05) 595.83 (45.37)a 668.80 (17.05)a,b 643.11 (21.43)a,b,c 633.84 (27.71)a,b,c 25.13 (4) 0.0000
24H 798.16 (17.27) 533.40 (18.52)a 631.66 (29.97)a,b 643.32 (54.40)a,b 601.23 (33.85)a,b,c 23.69 (4) 0.0001
48H 797.59 (26.24) 578.87 (8.92)a 657.57 (34.49)a,b 664.97 (41.12)a,b 622.71 (20.48)a,b,c 25.36 (4) 0.0000
The results were expressed as the median (IqR). The significant difference was determined by non-parametric test, Kruskal-Wallis test followed by Mann-Whitney U
post-hoc test with p < 0.05 indicates statistically significant difference. ap < 0.05 versus control group (MW); bp < 0.05 versus KA group (MW); cp < 0.05 versus KA + TH
group (MW)
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KA administration (Table 4). Therefore, TH pre-
treatment significantly attenuated a decrease of in TAS
level induced by KA.
There was also a significant difference (p < 0.05) in the
TAS level between KA-treated groups and KA-induced
groups pre-treated with ASP and TPM, respectively,
after 2 h, 24 h and 48 h of KA administration (Table 4).
In addition, there was a significant difference (p < 0.05)
in the TAS level between KA-induced groups pre-
treated with TH and KA-induced groups pre-treated
with ASP of 2 h, 24 h, and 48 h of KA administration
and between KA-induced groups pre-treated with TH
and KA-induced groups pre-treated with TPM of 2 h of
KA administration (Table 4). This indicated that pre-
treatment with TH showed a more pronounced protect-
ive effect compared with the ASP + KA-treated treated
groups.Fig. 1 In the photomicrographs, representative image of cresyl violet stain
challenge were presented. Arrows indicate the viable cell under cresyl viole
morphology, exhibiting round nuclei stained with cresyl violet-stained. In K
pyknotic, indicated by arrowheads (b and e). Neurons remained normal at
μm. Magnification: 200x magnificationEffect of KA-induced excitotoxicity on the number of
viable cells in the piriform cortex
To evaluate the protective effect of TH, ASP and TPM
against KA-induced neuronal death, we performed cresyl
violet staining to quantify the number of viable cells in
the piriform cortex. Systemic administration of KA
caused neuronal death in the piriform cortex, as recog-
nized by pyknotic appearance and subsequently has less
viable cells, in comparison with the control groups,
which have more viable cells in the piriform cortex, as
shown in Fig. 1(a) -(e), Fig. 2(a) - (e), and Fig. 3(a) -(e).
Viable cells were defined as cells with normal morph-
ology, exhibiting round nuclei stained with cresyl violet.
Statistical analysis of the number of viable cells in the
piriform cortex indicated that there was a a significant
difference (p < 0.05) in the number of viable cells Table 5
[2 h subgroups = χ2 (4) = 24.46, (N = 30), p = 0.0001; 24 h
subgroups = χ2 (4) = 25.96, (N = 30), p = 0.0000; 48 hing (a–e), and FJC staining (f–j) in the piriform cortex after 2 h of KA
t staining (a–e). Viable cells were defined as cells with normal
A- treated groups and ASP+ KA treated groups, neurons appeared
2 h after KA administration in the piriform cortex, (f–j). Scale bars: 100
Fig. 2 In the photomicrographs, representative image of cresyl violet staining (a–e) and FJC staining (f–j) in the piriform cortex after 24 h of KA
challenge were presented. Arrows indicate the viable cell under cresyl violet staining (a–e). In KA- treated groups and ASP+ KA treated groups,
neurons appeared pyknotic, indicated by chevron (b and b). Neuronal degeneration, indicated by arrowheads, was detected after 24 h of KA
administration in the piriform cortex (g–j). Scale bars: 100 μm. Magnification: 200x magnification
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hoc test revealed that there was a significant difference
(p < 0.05) in the number of viable cells between the con-
trol and all the treatment groups that received KA, for
all 2 h, 24 h and 48 h subgroups of KA administration
(Table 5). This indicated that there was less viable cells
in KA- treated, TH + KA treated, TPM+ KA treated andFig. 3 In the photomicrographs, representative image of cresyl violet stain
challenge were presented. Arrows indicate the viable cell under cresyl viole
groups, ASP+ KA treated groups, there neurons appeared pyknotic, indicat
was detected after 48 h of KA administration in the piriform cortex (f–j). ScASP + KA treated groups and they were significantly re-
duced as compared with the relative control groups after
2 h, 24 h and 48 h following KA administration, respect-
ively (Table 5).
There was also a significant difference (p < 0.05) in the
number of viable cells between KA-treated groups and
KA-induced groups pre-treated with TH after 2 h anding (a–e) and FJC staining (f–j) in the piriform cortex after 48 h of KA
t staining (a–e). In KA- treated groups, TH + KA groups and TPM + KA
ed by chevron a–e). Neuronal degeneration, indicated by arrowheads,
ale bars: 100 μm. Magnification: 200x magnification
Table 5 Effect of KA-induced excitotoxicity on the number of viable cells in the piriform cortex
Subgroups Viable cells
Median (IqR) (n = 6)
Kruskal-Wallis test (N = 30)
CONTROL KA TH + KA TPM + KA ASP + KA χ2 stat (df) p value
2H 279.17 (25.33) 135.17 (53.75)a 202.00 (38.42)a,b 158.00 (3.41)a,c 133.00 (27.75)a,c 24.46 (4) 0.0001
24H 271.83 (22.24) 110.50 (31.25)a 153.83 (57.00)a,b 129.00 (9.00)a,c 90.34 (24.25)a,b,c 25.96 (4) 0.0000
48H 251.00 (40.50) 127.67 (54.42)a 160.84 (23.42)a 141.00 (14.41)a,c 80.00 (10.17)a,b,c 24.58 (4) 0.0001
The results were expressed as the median (IqR). The significant difference was determined by non-parametric test, Kruskal-Wallis test followed by Mann-Whitney U
post-hoc test with p < 0.05 indicates statistically significant difference. ap < 0.05 versus control group (MW); bp < 0.05 versus KA group (MW); cp < 0.05 versus KA + TH
group (MW)
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groups and KA-induced groups pre-treated with TH
after 48 h of KA administration (Table 5). Therefore, TH
pre-treatment significantly attenuated a decrease in the
number of viable cells induced by KA.
In addition, there was a significant difference (p < 0.05)
in the number of viable cells between KA-induced
groups pre-treated with TH and KA-induced groups
pre-treated with ASP, and between KA-induced groups
pre-treated with TH and KA-induced groups pre-treated
with TPM after 2 h, 24 h and 48 h of KA administration
(Table 5). This indicated that pretreatment with TH
showed a more protective effect than ASP + KA-treated
and TPM+KA-treated groups.
Effect of KA-induced excitotoxicity on the number of
FJC-positive cells in the piriform cortex
In the present study, the degenerated neurons were la-
belled using FJC staining. Histological observation of the
FJC-stained slides revealed that FJC-positive cells were
absent in all control groups but were identified in all
treatments groups that received KA, except in 2 h
treated group, as shown in Fig. 1(f ) -(j). The FJC-stained
neurons, which emitted bright green fluorescence, could
be identified clearly in the 24 h and 48 h post-KA ad-
ministration, as shown in Fig. 2(f ) - (j) and Fig. 3(f ) -(j).
Statistical analysis of the number of number of FJC-
positive cells in the piriform cortex indicated that
there was a significant difference (p < 0.05) in the
number of FJC-positive cells between the groups, for
both of 24 h [χ2 (4) = 26.17, (N = 30), p = 0.0000] andTable 6 Effect of KA-induced excitotoxicity on the number of FJC-p
Subgroups FJC-positive cells
Median (IqR) (n = 6)
CONTROL KA TH + KA TP
24H 0 225.50 (54.25)a 101.67 (30.08)a,b 15
48H 0 168.67 (18.00)a 94.00 (7.16)a,b 13
The results were expressed as the median (IqR). The significant difference was dete
post-hoc test with p < 0.05 indicates statistically significant difference. ap < 0.05 vers
TH group (MW)48 h [χ2 (4) = 24.71, (N = 30), p = 0.0001] of KA ad-
ministration (Table 6). As predicted, KA administra-
tion inflicted neuronal degeneration in the piriform
cortex of KA-treated groups at 24 h and 48 h after
KA administration, which was not the case in the
control, where there was no FJC -positive cells ob-
served [see Fig. 1(f) -(j), Fig. 2(f) - (j) and Fig. 3(f) -(j)].
Further examination of the data revealed that there
were significant differences (p < 0.05) in the number of
FJC-positive cells between KA- treated groups and KA-
treated groups that received pretreatment of TH, ASP
and TPM at 24 h of KA administration (Table 6). The
number of FJC-positive cells in the piriform cortex of
24 h of KA administration were reduced by pretreat-
ment with TH, TPM and ASP. This indicated that
pretreatment with TH, ASP and TPM did have some
protective effect in KA-induced neuronal degeneration
in the piriform cortex after 24 h KA administration.
At 48 h of KA administration, the quantitative analysis
of FJC-positive cells showed that there was a significant
difference (p < 0.05) between KA-treated groups and
KA-induced groups pre-treated with TH and TPM but
there was no significance difference (p > 0.05) between
KA-treated and KA-induced groups pre-treated with
ASP (Table 6). This suggested that TH and TPM pre-
treatment ameliorated the KA-induced neuronal degen-
eration in the piriform cortex of 48 h of KA
administration but not the case in the pretreatment with
ASP.
In addition, quantitative analysis of neuronal degener-
ation using FJC staining revealed there was a significantositive cells in the piriform cortex
Kruskal-Wallis test (N = 30)
M + KA ASP + KA χ2 stat (df) p value
1.33 (55.34)a,b,c 161.50 (53.92)a,b,c 26.17 (4) 0.0000
6.67 (40.50)a,b,c 168.84 (32.66)a,c 24.71 (4) 0.0001
rmined by non-parametric test, Kruskal-Wallis test followed by Mann-Whitney U
us control group (MW); bp < 0.05 versus KA group (MW); cp < 0.05 versus KA +
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treated with TH and KA-induced groups pre-treated
with ASP and between KA-induced groups pre-treated
with TH and KA-induced groups pre-treated with TPM
of 24 h and 48 h of KA administration. This indicated
that pretreatment with TH showed more protective ef-
fect than ASP + KA-treated and TPM+ KA-treated
groups.
Discussion
In this experiment, several parameters such as behav-
ioral changes, oxidative stress related markers, and neur-
onal degeneration were examined to confirm the
protective effect of TH on KA-induced excitotoxicity in
a rat model. The administration of KA has been shown
to induce a sequence of well-characterized seizures syn-
drome [2, 7]. Overactivation of glutamate receptors by
KA has resulted in the increased production of ROS,
which are mediators of oxidative stress. Oxidative stress
has been suggested to play an important role in the
mechanism of excitotoxicity and neurodegeneration on
the different brain regions. Oxidative stress can cause
cellular damage and production of ROS, which oxidizes
membrane lipids, protein and DNA. There are growing
evidences suggesting that oxidative stress has been im-
plicated in the mechanism of excitotoxicity and neuro-
degeneration on different brain regions after the
induction of KA on rodents [5, 6]. Brain is considered to
be very vulnerable to oxidative stress because of its great
consumption of energy, oxygen and glucose, large
amount of peroxidizable polyunsaturated fatty acids and
relatively low antioxidant capability.
In the present study, we have demonstrated that ad-
ministration of KA (15 mg/kg body weight; s.c.) induced
epileptic seizures. All KA- treated groups and KA-
treated groups that received pretreatment of TH, ASP
and TPM had a status epilepticus. In the OFT, KA-
treated group has an increased in the locomotor activity
(based on number of line crossing) and hyperactivity.
Next, we examined TBARS levels and TAS levels in the
cerebral cortex after 2 h, 24 h and 48 h of KA adminis-
tration. These parameters were associated with oxidative
neuronal damage. TBARS levels were elevated whereas,
TAS levels was decreased in KA-treated groups after 2 h,
24 h and 48 h of KA administration, as compared to con-
trol group. In addition, KA-induced epileptic seizure
caused neuronal degeneration in the piriform cortex. Our
result showed that degenerated neurons were not detected
after 2 h but after 24 h and 48 h of KA administration in
the piriform cortex.
Previous reports have shown that lipid peroxidation
was enhanced by KA in the piriform cortex after 8 h and
16 h, continued to increase and gradually decreased after
48 h and 5 days [6, 21, 32]. The elevated TBARS levelsafter 2 h of KA administration suggest an increased lipid
peroxidation during an early phase of the excitotoxic
damage. Sarkar et al. [33], Riba-Bosch and Pérez-Clausell
[34] and Hopkins et al. [35] have reported that degener-
ating neurons in the piriform cortex could be detected
after 4 h, 6 h and 8 h of KA administration and degener-
ating neurons continued to increase in number through-
out the affected areas, reaching its peak at 2 weeks and
gradually decreased by 2 months of KA administration.
This indicated that neurons in the piriform cortex were
undergoing degeneration as early as 4 h of KA adminis-
tration and there was a temporal progression of KA-
induced neurodegeneration as its continue to increase to
its peak and gradually decrease in the number as time
goes by after KA administration. Since an increase in
TBARS level and a decrease in TAS level occurred as
early as after 2 h of KA administration, this study sug-
gests that lipid is exposed to oxidative damage and
strongly indicates the oxidative stress as a possible
mechanism of neurodegeneration. Our results demon-
strated that oxidative stress was enhanced by KA in the
cerebral cortex after 2 h, 24 h and 48 h of KA
administration.
In this study, we have demonstrated that pretreatment
of TH (at dose of 1.0 g/kg body weight) could reduce
KA-induced neuronal degeneration in the piriform cor-
tex but had failed to prevent seizures induced by KA. In
addition, the increased locomotor activity in the OFT
was attenuated by TH pre-treatment. TH pre-treatment
also significantly reduced the oxidative stress, as shown
by an increase in TBARS level and a decrease in TAS
level. TH has been reported to contain many bioactive
compounds. Several studies have been conducted to
investigate the protective effects of specific bioactive
compound contained in TH against KA model of excito-
toxicity. For example, gallic acid, which is one of the bio-
active compound found in TH, has been shown to
attenuate the severity of seizure behaviors, reduced
neuronal apoptosis and reduced oxidative stress in KA-
induced excitotoxicity model [36]. Another bioactive
compound is caffeic acid. It has also been shown to pro-
vide protection on memory impairment and on oxidative
stress induced by KA [37]. These indicate that several
important compounds found in TH may play protective
roles against KA-induced neuronal degeneration, which
may act through their antioxidant activity. Other study
on propolis, which is another beehive product, appeared
to be effective in preventing KA-induced neuronal loss
in the regions of the hippocampus [11]. In addition,
propolis was found to attenuate KA-induced seizures
and KA-induced oxidative stress in the brain thought to
be due to its antioxidant property [11, 38]. These studies
suggested that these antioxidants provide protection
against KA-induced neuronal degeneration and seizures
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beneficial of TH may be due to its antioxidant property
which is attributed to the presence of flavonoids and
phenolic compounds [12, 13].
This study also determined the significance of a block-
ade of the COX pathway and the modulatory effect on
KARs, by comparing pretreatment between TH and ASP
and between TH and TPM in order to extend our un-
derstanding of the pharmacological mechanism of TH.
Pretreatment with TH helped to reduce the KA-induced
behavioral change, oxidative stress and neuronal degen-
eration and it showed a more protective effect than
ASP + KA-treated and TPM+KA-treated groups. Other
study demonstrated that ASP alone did not have any effect
on the KA-induced neurodegeneration, while combination
of ASP and esculetin, an inhibitor of lipoxygenase (LOX),
prevented KA-induced neuronal death [20]. In addition,
the findings from Baran et al. [39] and Minutoli et al. [40]
studies have suggested that the protection against KA-
induced neurodegeneration via combination of COX and
LOX inhibitor pathways or via dual inhibitor of COX and
LOX pathways were more effective than using only either
a COX inhibitor or a LOX inhibitor alone. Administration
of KA has caused the activation of phospholipase A
followed by an increase level of arachidonic acid [41]. Ara-
chidonic acid then undergoes degradation by COX or
LOX, which form prostaglandins and leukotriene, respect-
ively. The free radicals are formed from prostaglandins
synthesis and studies have demonstrated the formation of
free radicals due to the action of KA [6, 42]. With the dual
inhibition of COX/LOX, the effect of KA-induced excito-
toxicity could be attenuated, which blocked both leukotri-
ene and prostaglandins production. This augments its
synergistic protective effect, directly through the anti-
inflammatory mechanisms and indirectly through the
anti-radical activity. This may well indicate that blocking
of both COX and LOX pathways are necessary to protect
the brain against KA-induced seizures and KA-induced
neurotoxicity. Furthermore, studies have demonstrated
that topiramate has some protective effect against KA-
induced seizures and KA-induced hippocampal neurotox-
icity [21, 43]. The discrepancy between the present and
previous studies might probably due to differences in ex-
perimental conditions such as administration route of KA,
administration route of drugs, animal age (young, middle-
aged or aged), animal strain and animal species (rat or
mice).
Conclusion
Administration of KA (at a dose of 15 mg/kg body
weight; s.c.) induced seizures and resulted in an increase
in locomotor activity in KA-treated animals. An in-
creased lipid peroxidation and a decreased total antioxi-
dant status suggestive of an oxidative stress wereobserved during an early phase of the excitotoxic
damage that preceded neurodegeneration. This study
suggests that oxidative stress could be a possible mech-
anism of neurodegeneration and TH attenuates KA-
induced oxidative stress. Hence, TH reduces neurode-
generation in the rat cerebral cortex after 2 h, 24 h and
48 h of KA administration due to its antioxidant
property.
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